| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/28/2023 | 128.45% | JMP Securities | → $22 | Initiates Coverage On | → Market Outperform |
| 05/23/2023 | 97.3% | Piper Sandler | $16 → $19 | Maintains | Overweight |
| 08/16/2022 | 34.99% | Wells Fargo | $12 → $13 | Maintains | Equal-Weight |
| 04/22/2022 | 66.15% | Piper Sandler | → $16 | Initiates Coverage On | → Overweight |
| 10/12/2021 | 45.38% | Morgan Stanley | $13 → $14 | Maintains | Equal-Weight |
| 07/16/2021 | 24.61% | Morgan Stanley | $11 → $12 | Maintains | Equal-Weight |
| 02/22/2021 | 14.23% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
| 02/19/2021 | 14.23% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
| 11/06/2020 | 24.61% | Credit Suisse | $11 → $12 | Maintains | Neutral |
| 11/06/2020 | 24.61% | Morgan Stanley | $11 → $12 | Maintains | Equal-Weight |
| 09/30/2020 | -6.54% | Wells Fargo | → $9 | Downgrades | Overweight → Equal-Weight |
| 08/07/2020 | 14.23% | Morgan Stanley | $10 → $11 | Maintains | Equal-Weight |
| 07/15/2020 | 3.84% | Morgan Stanley | $11 → $10 | Maintains | Equal-Weight |
| 06/01/2020 | 14.23% | Credit Suisse | $12 → $11 | Maintains | Neutral |
| 05/11/2020 | 14.23% | HC Wainwright & Co. | $13 → $11 | Reiterates | → Neutral |
| 05/07/2020 | 14.23% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
| 04/30/2020 | 55.76% | Wells Fargo | $16 → $15 | Maintains | Overweight |
| 04/15/2020 | 24.61% | Morgan Stanley | $13 → $12 | Maintains | Equal-Weight |
| 07/10/2019 | — | Credit Suisse | Assumes | → Neutral | |
| 03/27/2019 | 45.38% | Morgan Stanley | $11 → $14 | Upgrades | Underweight → Equal-Weight |
| 02/25/2019 | 45.38% | HC Wainwright & Co. | $11.5 → $14 | Upgrades | Sell → Neutral |
| 01/24/2019 | 34.99% | JP Morgan | $11 → $13 | Upgrades | Underweight → Neutral |
| 11/07/2018 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 11/07/2018 | — | Credit Suisse | Downgrades | Outperform → Neutral |
What is the target price for Ironwood Pharmaceuticals (IRWD)?
There is no price target for Ironwood Pharmaceuticals
What is the most recent analyst rating for Ironwood Pharmaceuticals (IRWD)?
There is no analyst for Ironwood Pharmaceuticals
When is the next analyst rating going to be posted or updated for Ironwood Pharmaceuticals (IRWD)?
There is no next analyst rating for Ironwood Pharmaceuticals
Is the Analyst Rating Ironwood Pharmaceuticals (IRWD) correct?
There is no next analyst rating for Ironwood Pharmaceuticals